LifeMD Financial Statements From 2010 to 2025

LFMD Stock  USD 5.71  0.23  3.87%   
LifeMD financial statements provide useful quarterly and yearly information to potential LifeMD Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on LifeMD financial statements helps investors assess LifeMD's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting LifeMD's valuation are summarized below:
Gross Profit
188.4 M
Profit Margin
(0.09)
Market Capitalization
264.8 M
Enterprise Value Revenue
1.1999
Revenue
212.5 M
There are over one hundred nineteen available fundamental ratios for LifeMD, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of LifeMD's last-minute performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 214.1 M, whereas Enterprise Value is projected to grow to (18.8 T).

LifeMD Total Revenue

223.08 Million

Check LifeMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10 M, Interest Expense of 2.3 M or Selling General Administrative of 76.3 M, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0138 or Days Sales Outstanding of 14.8 M. LifeMD financial statements analysis is a perfect complement when working with LifeMD Valuation or Volatility modules.
  
Check out the analysis of LifeMD Correlation against competitors.

LifeMD Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets76.1 T72.5 T9.3 T
Slightly volatile
Short and Long Term Debt Total16 T15.2 T1.9 T
Slightly volatile
Other Current Liabilities38.7 T36.8 T4.7 T
Slightly volatile
Total Current Liabilities63.3 T60.3 T7.7 T
Slightly volatile
Property Plant And Equipment Net6.7 T6.4 T820.1 B
Slightly volatile
Accounts Payable16.8 M16 MM
Slightly volatile
Cash36.8 T35 T4.5 T
Slightly volatile
Cash And Short Term Investments36.8 T35 T4.5 T
Slightly volatile
Net Receivables8.6 T8.2 T1.1 T
Slightly volatile
Common Stock Total Equity377.1 K362.9 K338.6 K
Slightly volatile
Common Stock Shares Outstanding43.3 M41.2 M16.5 M
Slightly volatile
Liabilities And Stockholders Equity76.1 T72.5 T9.3 T
Slightly volatile
Inventory2.9 T2.8 T358.4 B
Slightly volatile
Other Stockholder Equity242.3 T230.8 T29.6 T
Slightly volatile
Total Liabilities80.3 T76.5 T9.8 T
Slightly volatile
Property Plant And Equipment Gross8.3 M7.9 M1.4 M
Slightly volatile
Total Current Assets51.2 T48.7 T6.2 T
Slightly volatile
Short Term Debt9.4 TT1.1 T
Slightly volatile
Common Stock386.6 K422.9 K347.2 K
Slightly volatile
Short and Long Term Debt8.9 M8.4 M1.5 M
Slightly volatile
Other Liabilities1.2 M1.2 M666.5 K
Slightly volatile
Capital Stock401.9 K423.1 K1.2 M
Slightly volatile
Non Current Liabilities Other95 K100 K501.5 K
Slightly volatile
Intangible Assets16.6 M15.8 M4.6 M
Slightly volatile
Capital Lease Obligations7.1 M6.8 M1.1 M
Slightly volatile
Property Plant Equipment759.2 K547.9 K297.3 K
Slightly volatile
Warrants4.5 M5.3 MM
Slightly volatile
Capital Surpluse154.5 M205.9 M108.7 M
Slightly volatile
Preferred Stock Total Equity112126137
Slightly volatile
Other Assets0.80.90.9813
Slightly volatile
Long Term Debt11.1 M9.9 M17 M
Slightly volatile
Good Will1.6 T1.8 TT
Slightly volatile

LifeMD Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10 M9.5 M2.1 M
Slightly volatile
Interest Expense2.3 M2.2 M899.3 K
Slightly volatile
Selling General Administrative76.3 M72.7 M21.7 M
Slightly volatile
Total Revenue223.1 M212.5 M54.6 M
Slightly volatile
Gross Profit254.5 M242.4 M53.8 M
Slightly volatile
Other Operating Expenses240 M228.6 M67.7 M
Slightly volatile
Total Operating Expenses214.8 M204.5 M60 M
Slightly volatile
Selling And Marketing Expenses108.2 M103 M31.7 M
Slightly volatile
Research Development10 M9.5 M1.9 M
Slightly volatile
Discontinued Operations1.1 M1.1 M564 K
Slightly volatile
Reconciled Depreciation10 M9.5 MM
Slightly volatile
Preferred Stock And Other Adjustments2.3 M2.8 MM
Slightly volatile
Non RecurringM3.4 M3.7 M
Slightly volatile

LifeMD Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.8 M12.2 M5.3 M
Slightly volatile
Depreciation10 M9.5 MM
Slightly volatile
End Period Cash Flow36.8 M35 M10.1 M
Slightly volatile
Begin Period Cash Flow34.8 M33.1 M7.8 M
Slightly volatile
Dividends Paid3.8 M3.6 M1.2 M
Slightly volatile
Change To Netincome11.3 M20.6 M7.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.910.95983.5781
Slightly volatile
Dividend Yield0.01380.01520.0117
Slightly volatile
Days Sales Outstanding14.8 M14.1 M1.8 M
Slightly volatile
Average Payables12.8 M12.2 M4.5 M
Slightly volatile
Stock Based Compensation To Revenue0.05470.05760.1749
Slightly volatile
Capex To Depreciation1.521.21541.1246
Slightly volatile
Sales General And Administrative To Revenue0.320.3420.8084
Slightly volatile
Average Inventory3.1 M2.9 M1.2 M
Slightly volatile
Research And Ddevelopement To Revenue0.03750.03580.0211
Slightly volatile
Capex To Revenue0.03720.05430.0264
Slightly volatile
Cash Per Share892.2 K849.7 K108.9 K
Slightly volatile
Intangibles To Total Assets0.02660.0280.2869
Slightly volatile
Current Ratio0.850.80880.9931
Pretty Stable
Receivables Turnover0.00.036.2572
Pretty Stable
Capex Per Share0.150.280.0867
Slightly volatile
Average Receivables1.8 M1.7 M703.8 K
Slightly volatile
Revenue Per Share5.415.15711.8283
Slightly volatile
Interest Debt Per Share387.9 K369.4 K47.3 K
Slightly volatile
Debt To Assets0.230.210.2392
Slightly volatile
Ebt Per Ebit0.781.13510.9579
Slightly volatile
Quick Ratio0.630.76240.7341
Pretty Stable
Net Income Per E B T0.751.03030.9269
Pretty Stable
Cash Ratio0.410.58090.476
Slightly volatile
Days Of Sales Outstanding14.8 M14.1 M1.8 M
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.01080.01130.9223
Slightly volatile
Fixed Asset Turnover0.00.0192
Very volatile
Debt Ratio0.230.210.2392
Slightly volatile
Price Sales Ratio0.910.95983.5781
Slightly volatile
Asset Turnover0.00.02.7382
Pretty Stable
Gross Profit Margin0.631.1410.7743
Slightly volatile

LifeMD Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap214.1 M203.9 M70.2 M
Slightly volatile

LifeMD Fundamental Market Drivers

Forward Price Earnings27.027
Cash And Short Term Investments35 T

LifeMD Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About LifeMD Financial Statements

LifeMD stakeholders use historical fundamental indicators, such as LifeMD's revenue or net income, to determine how well the company is positioned to perform in the future. Although LifeMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in LifeMD's assets and liabilities are reflected in the revenues and expenses on LifeMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LifeMD Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14.5 T15.2 T
Total Revenue212.5 M223.1 M
Cost Of Revenue-29.9 M-28.4 M
Stock Based Compensation To Revenue 0.06  0.05 
Sales General And Administrative To Revenue 0.34  0.32 
Research And Ddevelopement To Revenue 0.04  0.04 
Capex To Revenue 0.05  0.04 
Revenue Per Share 5.16  5.41 
Ebit Per Revenue(0.08)(0.08)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out the analysis of LifeMD Correlation against competitors.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.53)
Revenue Per Share
5.157
Quarterly Revenue Growth
0.432
Return On Assets
(0.15)
Return On Equity
(24.63)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.